-
Gilead Sciences, Inc. (GILD) JPMorgan Annual Healthcare Conference - (Transcript)
13 Jan 2025 23:05 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) JPMorgan Annual … O'Day, Chairman and CEO. And following that presentation, we …
-
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
20 Jan 2025 01:40 GMT
… just before JPM Week began, Gilead Sciences, Inc. said it will partner … platform bodes well for the CEO Investor Conference.
“BIO’s … and carries into the BIO CEO & Investor Conference. That … industry, and February’s BIO CEO & Investor Conference.
“It …
-
Galapagos CEO Tells JPM Audience the Rationale for Planned Business Separation
17 Jan 2025 03:13 GMT
When Galapagos and Gilead Sciences entered a global drug R… biotech industry have evolved, Galapagos CEO Paul Stoffels said during a … -care manufacturing, Perettie said.
Zelis CEO Amanda Eisel shares her perspective …
-
The Children's Inn at NIH Announces $1 Million Grant From Gilead Sciences, Inc.
22 Nov 2024 21:45 GMT
… Jennie Lucca, The Inn’s CEO. “Gilead is a valued partner … President, ESG and Corporate Citizenship, Gilead Sciences. “Our contribution demonstrates our continued … to 3,000 families.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company …
-
Gilead Sciences stock hits 52-week high at $98.34
11 Nov 2024 16:09 GMT
… sector.
In other recent news, Gilead Sciences has announced its earnings results … top executives, including Chairman and CEO Daniel O'Day, presented … associated with forward-looking statements.
Gilead Sciences' recent stock performance aligns …
-
Cancer Gene Therapy Market Projected to Reach $11.4 Billion by 2030 at a 23.3% CAGR: Gilead Sciences, Genulex, Amgen Inc
07 Oct 2024 06:38 GMT
… Inc.
Glaxosmithkline PLC
Kayropharma Therapeutics
Gilead Sciences
Adapta Immue
Genulex Corporation
SynerGene … market domain.
Pawan Kumar, the CEO of Allied Market Research, is …
-
Dr Reddy's Share Price in Focus after Agreement with Gilead Sciences to Produce Lenacapavir
03 Oct 2024 06:55 GMT
… into a significant collaboration with Gilead Sciences to manufacture and commercialize the … has formalized a partnership with Gilead Sciences Ireland UC, one of the … remains severe. Dr. Reddy’s CEO of API and Services, Deepak …
-
As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials
30 Jan 2025 20:57 GMT
… to progress in 2025, Recursion CEO Chris Gibson, PhD, told GEN … 2014 for certain blood cancers (Gilead Sciences’ Zydelig® [idelalisib], indicated in combination …
-
Why Gilead Sciences Stock Thrashed the Market Today
13 Sep 2024 00:13 GMT
… in the clinical sphere for Gilead Sciences (GILD 2.74%) on Thursday … ;s performance, Gilead quoted its CEO Daniel O'Day as … has positions in and recommends Gilead Sciences. The Motley Fool has a …
-
Gilead Sciences, Genesis Therapeutics enter into strategic collaboration to discover, develop novel therapies
10 Sep 2024 20:01 GMT
Foster City: Gilead Sciences, Inc. and Genesis Therapeutics, Inc. … .D., Executive Vice President, Research, Gilead Sciences. “We look forward to working … Feinberg, Ph.D., founder and CEO of Genesis. "We have …
About
© 1995-2025